Functional Constipation: Pathophysiology, evaluation, and management

Abstract

SummaryBackgroundFunctional constipation (FC), a disorder of the gut–brain interaction of multifactorial pathophysiology that is prevalent in paediatrics. It is associated with bothersome symptoms, increased healthcare costs, disgruntled caregivers and impaired health‐related quality of life. Paediatric FC is a clinical diagnosis based on the Rome IV criteria and is characterised by decreased bowel movement frequency and/or hard, painful stools and can be complicated by retentive faecal incontinence. Stressful life events, difficult temperaments and emotional and behavioural challenges have been implicated in increasing risk of developing paediatric FC.AimsTo provide current concepts in pathophysiology, evaluation and management of paediatric FC.MethodsWe reviewed pertinent literature after a comprehensive search utilising PubMed with keywords FC, chronic childhood constipation and paediatric FC.ResultsIn the last decade, advances in our understanding of paediatric FC have changed the landscape of diagnosing and treating this disorder. Although polyethylene glycol is the first‐line treatment for maintenance of FC, the armamentarium of therapeutics has expanded including the first Food and Drug Administration‐ agent, linaclotide, for children 6–17 years of age in conjunction with more emphasis on behavioural and physical therapy interventions.ConclusionsTreatment approach to paediatric FC should be individualised and integrated focusing on parental education, lifestyle and behavioural modifications, and pharmacological therapy to maximise therapeutic success. This review highlights advances in pathophysiology, diagnosis and treatment of FC in children.